[28] He discovered molecules in the monster's saliva "that caused inflammation of the pancreas in test animals"
Beyond glycemic control, GLP-1 based compounds may also reduce cardiovascular risk factors and promote kidney function, liver function, and energy metabolism [78]
Starting Dose In Insulin Nave Patients Recommended Starting Dosage In Patients With Type 1 Diabetes Mellitus The recommended starting dose of TRESIBA in insulin nave patients with type 1 diabetes is approximately one third to one half of the total daily insulin dose
however, current evidence does not indicate a higher risk of infection or obesity-related cancer
More serious but rare side effects may include pancreatitis or allergic reactions
(PubMed) You WC, Brown LM, Zhang L, et al